+39 02 610346.1 - info@newron.com Glossary | Sitemap | Cookie policy Home About Us Research and Drug Development Investors and Media Contact Us Analyst report ‹ › Discovering and developing innovative therapeutics for CNS disorders Welcome to the Newron Pharmaceuticals website. We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain. LATEST PRESS RELEASES 14 JUL Newron Receives FDA Orphan Drug Designation for Sarizotan for the Treatment of Rett Syndrome 25 JUN Newron receives positive opinion for ODD for Sarizotan to treat patients with Rett Syndrome from EMA’s COMP 15 MAY Zambon Launches Xadago® (Safinamide) For Patients With Mid- To Late-Stage Parkinson’s Disease In Germany 30 APR Newron Completes CHF24.3M/US$25.5M in Private Placement from Leading EU and US Investors 24 MAR Newron Shareholders Authorize Allocation of Additional Shares to Support Multiple Clinical Programs 4 MAR Newron to Present at the 27th Annual ROTH Conference View All NEWRON SHARE PRICE EVENTS 20 OCT 14th Annual BIO Investor Forum October 20-21, 2015 - Parc 55, San Francisco, CA - USA 1 OCT Investora Zürich 2015 September 30, October 1, 2015 - ConventionPoint, SIX Swiss Exchange, Zürich - Switzerland 10 SEP the 22nd annual NewsMakers in the Biotech Industry September 10, 2014 - Millennium Broadway Hotel - New York City, USA View Event Calendar About Us Overview Strategy Our people History Research & Drug Development Therapeutic Focus Pipeline Partners Publications Media News Events Reports, presentations & webcasts Email alert Investors Stock information Financial Calendar Financial Report Shareholder FAQs Disclaimer © Newron 2013. All Rights Reserved

+39 02 610346.1 - info@newron.com Glossary | Sitemap Home About Us Research and Drug Development Investors and Media Contact Us Analyst report 2015 Investors and Media / Downloads / Reports, Presentations & Webcasts / 2015 News Stock Information Events Financial Calendar Shareholder FAQs Corporate Governance and Structure Downloads Financial report and accounts Reports, Presentations & Webcasts 2015 2014 2013 2012 2011 2010 2009 2008 2007 Email Alerts 2015 VALUATIONLAB report 20/05/2015 Media, investors and analyst conference - 2014 results MP3 file 04/03/2015 Media and analyst conference - 2014 results presentation 04/03/2015 About Us Overview Strategy Our people History Research & Drug Development Therapeutic Focus Pipeline Partners Publications Media News Events Reports, presentations & webcasts Email alert Investors Stock information Financial Calendar Financial Report Shareholder FAQs Disclaimer © Newron 2013. All Rights Reserved